The latest health and social care news and a look at research and development into the treatment of common and rare diseases alike. We also look at the vital changes being made to help deliver effective healthcare through the digital transformation within the NHS.
Afon Technology, founded by Dr Sabih Chaudhry in 2019, has been a leader in diabetes innovation with its Glucowear™ device, the world’s first non-invasive glucose sensor that continuously monitors blood sugar levels in real-time.
Kristoffer From, CEO of Liva Healthcare and Simon Pickup, UK Managing Director at Liva Healthcare share their thoughts on why obesity is key to tackling the root cause of Type 2 diabetes
A recent report from Asthma UK has shown that nine in ten people (88%), living with asthma in England are in favour of sharing their data to improve NHS services
As the European Parliament marks one year until the 2019 European elections, Mental Health Europe says EU states must reform outdated laws to show once and for all that people with psychosocial disabilities have a right to be heard
Candice Ward, Lead CDEP Educator from Cambridge Diabetes Education Programme (CDEP) details online diabetes competency training, including the importance of improving standards and reducing variation
Charity launches guide urging individuals and organisations in rural communities to take action to become more dementia friendly, for Dementia Action Week (21-27 May)
In an interview, Franz-Josef Wagner tells Elena Posth from Pfalzklinikum AdöR about his experiences as an ex-user of mental health services in the Rhineland-Palatinate region of Germany
Research carried out for the first time by Rare Disease UK indicates almost all patients and carers living with a rare disease have felt anxious, stressed and low
According to the recent CIPD survey, people coming into work when they are ill also known as ‘presenteeism’ has more than tripled since 2010, with 86% of employees admitting they had observed presenteeism in the workplace
Life Sciences sector responds to the Business, Energy and Industrial Strategy (BEIS) Committee report on the impact of Brexit on the pharmaceutical sector
